Indian custom fine chemical contract manufacturing organizations (CMO) are no longer satisfied with increasing their share of the pharmaceutical intermediates market and have started to target the high-value, high-tech active pharma ingredient (API) sector, which until now was served only by European and North American competitors including BASF, Cambrex, and Degussa. Indian firms such as...
Article / Feb 15, 2006
Fine Chemicals - Indian Firms Tear Into Overseas API Markets
Chemical Week, 15 February 2006